Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis Efficacy and Safety Study Comparing CPL409116to Placebo in Participants With Active Rheumatoid Arthr ...
A 12-week, Phase II, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing CPL409116 to Placebo, in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to MTX A 12-week, Phase II, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing CPL4 ...
Rheumatoid Arthritis
Drug: CPL409116;Other: Placebo
Celon Pharma SA
National Center for Research and Development, Poland